<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065491</url>
  </required_header>
  <id_info>
    <org_study_id>MPT_trial_2016</org_study_id>
    <nct_id>NCT03065491</nct_id>
  </id_info>
  <brief_title>Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function</brief_title>
  <official_title>Effect of Red Yeast Rice, Phytosterols and L-tyrosol on Lipid Profile and Endothelial Function: a Double-blind, Placebo-controlled, Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A large body of evidence confirm the cholesterol lowering effect of red yeast rice,
      phytosterols and L-tyrosol. Because their mechanisms of action mime the ones of chemical
      statins and cholesterol absorption inhibitors, it is plausible that their association will
      provide a more relevant (and safe) LDL cholesterolemia reduction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      European Food Safety Authority approves some health claim related to the cardiometabolic
      effects of some nutraceuticals, and in particular of red yeast rice, phytosterols and
      L-tyrosol.

      In a previous study the investigators have already demonstrated the synergistic effect of red
      yeast rice and phytosterols in term of lipid-lowering activity.

      Preliminary data suggest that these nutraceuticals could also exert a positive effect on
      vascular health beyond the direct effects on serum lipids.

      No data are available on the combined effects of these dietary supplement in humans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 15, 2016</start_date>
  <completion_date type="Actual">February 17, 2017</completion_date>
  <primary_completion_date type="Actual">February 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-cholesterolemia absolute reduction from baseline and between groups</measure>
    <time_frame>8 weeks</time_frame>
    <description>Absolute reduction of LDL-cholesterolemia after 8 weeks of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LDL-cholesterolemia % reduction from baseline and between groups</measure>
    <time_frame>8 weeks</time_frame>
    <description>% reduction of LDL-cholesterolemia after 8 weeks of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Flow-mediated dilation improvement from baseline and between groups</measure>
    <time_frame>8 weeks</time_frame>
    <description>% vascular heath improvement after 8 weeks of treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Active treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combined nutraceutical</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Combined nutraceutical</intervention_name>
    <description>Plant sterols 800 mg + Red Yeast Rice containing 5 mg monacolin K + L-Tyrosol 50 mg per daily dose Oral administration: 1 tablet per day</description>
    <arm_group_label>Active treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral administration: 1 tablet per day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suboptimal LDL level (115-160 mg/dL)

          -  TG&lt;400 mg/dL

          -  Signed informed consent form

        Exclusion Criteria:

          -  Patients already affected by cardiovascular diseases (secondary prevention) or with
             estimated 10 years cardiovascular disease risk&gt; 10 years

          -  LDL-C&lt;115 mg/dL or &gt;160 mg/dL, TG&gt;400 mg/dL

          -  Obesity (BMI&gt;30 kg/m2) or diabetes mellitus

          -  Assumption of lipid lowering drugs or dietary supplements, or drugs potentially
             affecting the lipid metabolism

          -  Antihypertensive treatment not stabilized since at least 3 months

          -  Known current thyroid, gastrointestinal or liver diseases

          -  Any medical or surgical condition that would limit the patient adhesion to the study
             protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio Borghi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>S. Orsola-Malpighi University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>S. Orsola-Malpighi University Hospital</name>
      <address>
        <city>Bologna</city>
        <state>BO</state>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2017</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bologna</investigator_affiliation>
    <investigator_full_name>Claudio Borghi</investigator_full_name>
    <investigator_title>Principal Investigator, Professor Claudio Borghi</investigator_title>
  </responsible_party>
  <keyword>Red yeast rice</keyword>
  <keyword>Phytosterols</keyword>
  <keyword>L-Tyrosol</keyword>
  <keyword>Lipids</keyword>
  <keyword>LDL-cholesterol</keyword>
  <keyword>Endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Red yeast rice</mesh_term>
    <mesh_term>4-hydroxyphenylethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

